Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hikma Pharmaceuticals Ord Shs HKMPF

Hikma Pharmaceuticals PLC is a pharmaceutical company. The principal activities of the Company are the development, manufacture and marketing of a range of generic, branded and in-licensed pharmaceutical products. The Company operates through three segments: Injectables, Branded and Generics. The Injectables segment supplies hospitals across its markets with generic injectable products, supported by its manufacturing facilities in the United States, Europe and Middle East/North Africa (MENA). It is also engaged in the finished dosage form (FDF) business and has a manufacturing facility in Cleveland, Ohio. The Branded segment supplies branded generics and in-licensed patented products from its local manufacturing facilities to retail and hospital customers across the MENA region. The Generics segment supplies oral and other non-injectable generic and specialty products to the United States retail market, leveraging its manufacturing facility in Columbus, Ohio.


OTCPK:HKMPF - Post by User

Post by edwardebreen15on Aug 23, 2022 12:48am
157 Views
Post# 34913230

Opioids Market Size, Share, Trends and Forecast 2022-2027

Opioids Market Size, Share, Trends and Forecast 2022-2027

According to IMARC Group’s latest report, titled Opioids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global market reached a value of US$ 20.4 Billion in 2021. Opioids are pain-relieving compounds that are used to provide relief from severe pain. They are naturally occurring, synthetic or semi-synthetic compounds that bind to opioid receptors and activate them to block the pain signals. Some of the commonly available opioids include codeine, fentanyl, methadone, oxycodone, morphine and hydrocodone. They aid in managing pain caused by injuries or disease in the brain, spinal cord, intestines and other parts of the body. They are administered intravenously through injections or infusions and through managed oral and transdermal routes that involve the systemic distribution of the active ingredients over the skin.

 

Request for a PDF sample of this report: https://www.imarcgroup.com/opioids-market/requestsample

 

The global opioids market is primarily being driven by the increasing prevalence of cancer, obesity and chronic disorders among the masses. Moreover, the rising geriatric population and the escalating requirement for effective pain management solutions are providing a thrust to the market growth. In line with this, the widespread adoption of opioids to control post-surgical pain management and promote speedy recovery is favoring the market growth. Other factors, including the increasing health consciousness among the masses, along with extensive improvements in medical infrastructure, are creating a positive outlook for the market. Looking forward, IMARC Group expects the opioids market to reach US$ 24.9 Billion by 2027, exhibiting at a CAGR of 3.3% during 2022-2027.

 

Checkout Now: https://www.imarcgroup.com/checkout?id=4559&method=1

 

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

 

Competitive Landscape with Key Players:

  • Boehringer Ingelheim International GmbH
  • Hikma Pharmaceuticals PLC
  • Mallinckrodt plc
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Market Segmentation:

 

Breakup by Product Type:

  • Codeine 
  • Fentanyl
  • Methadone
  • Oxycodone
  • Morphine
  • Hydrocodone

 

Breakup by Application:

  • Pain Management
  • Cough Treatment
  • Diarrhea Treatment
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/opioids-market

 

Key highlights of the report:                                                    

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

 

Related Reports by IMARC Group:

RNA Interference Drug Delivery Market: https://www.imarcgroup.com/rna-interference-drug-delivery-market

Multiple Sclerosis Therapies Market: https://www.imarcgroup.com/multiple-sclerosis-therapies-market

Tangential Flow Filtration Market: https://www.imarcgroup.com/tangential-flow-filtration-market

Precision Medicine Market: https://www.imarcgroup.com/precision-medicine-market

Smart Pills Market: https://www.imarcgroup.com/smart-pills-market

 

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

 

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Bullboard Posts